Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether–lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial

BACKGROUND: Artemisinin-based combination therapy (ACT) resistant Plasmodium falciparum represents an increasing threat to Africa. Extended ACT regimens from standard 3 to 6 days may represent a means to prevent its development and potential spread in Africa. METHODS: Standard 3-day treatment with a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Malar J
Autori principali: Mhamilawa, Lwidiko E., Ngasala, Billy, Morris, Ulrika, Kitabi, Eliford Ngaimisi, Barnes, Rory, Soe, Aung Paing, Mmbando, Bruno P., Björkman, Anders, Mårtensson, Andreas
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7310382/
https://ncbi.nlm.nih.gov/pubmed/32576258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-020-03287-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi